Forecasts by Source (Autologous, Allogenic, Other Sources), by Application (Orthopaedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, Other Applications), by Type (Pure PRP, Leucocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)), by End-user (Hospitals, Clinics & Care Centres, Research Institutes, Other End-user) and Leading National Market Analysis PLUS Analysis of Leading Plasma Therapy Companies AND COVID-19 Recovery Scenarios
What is holding you back from greater success in the Plasma Therapy market? Though Plasma therapy is not new, the gap between plasma’s demand and supply continues to grow. Many plasma therapy companies are unable to make a move and grab this opportunity – why? In this report we have analysed the plasma therapy market to discover the key success areas to grow during this tough crisis. Buy this unique senior level report to find out how to succeed – TODAY.
Our 360+ page report provides 277 tables, 275 charts, and graphs. Read on to discover the most lucrative areas in the global plasma therapy industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing plasma therapy market. Buy our report to see how to exploit these opportunities in the global market.
Forecasts to 2031 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), Porter’s Five Forces Analysis, product profiles and commercial developments.
Discover sales predictions for the global plasma therapy market and submarkets Along with revenue prediction for the overall world market, there are 5 segmentations of the plasma therapy market, with forecasts for 4 product types, 6 applications, 3 sources, 4 end-users each forecasted at a global, regional, and country level, along with COVID-19 impact recovery pattern analysis for all segments.
Leading companies and the potential for market growth As per Visiongain analysis, the overall world revenue for plasma therapy will surpass US$816.5 million by 2031. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
What all Segments are Covered in the Report?
Global Plasma Therapy Market by Source (COVID-19 Impact Recovery Analysis Covered) • Autologous • Allogenic • Other Sources
Global Plasma Therapy Market by Application (COVID-19 Impact Recovery Analysis Covered) • Orthopaedics • Dermatology • Dental • Cardiac Muscle Injury • Nerve Injury • Other Applications
Global Plasma Therapy Market by Type (COVID-19 Impact Recovery Analysis Covered) • Pure PRP • Leucocyte-rich PRP • Pure Platelet-rich Fibrin (PRF) • Leukocyte-rich Fibrin (L-PRF)
Global Plasma Therapy Market by End-User (COVID-19 Impact Recovery Analysis Covered) • Hospitals • Clinics & Care Centres • Research Institutes • Other End-User
Global Plasma Therapy Market by Region (COVID-19 Impact Recovery Analysis Covered) • North America • Europe • Asia-Pacific • Latin America • Middle East • Africa
Which Key Players Are Leading the Global Market and how much share do they hold? The global market for blood plasma therapy is ascending and has made significant gains in therapeutic treatments. The players in the blood plasma market are striving to tap the opportunities that this market offers. Companies are trying to explore the available prospects by adopting various strategies such as: • Mergers and acquisitions. • Product launches. • Collaborations and partnerships.
Product approval is a major milestone facing all key competitors in the blood plasma therapy market. Several strategies were implemented by key market players between 2015 and April 2019. The threat of transmission of blood-borne diseases can make regulation that ensures the safety and efficacy of blood plasma proteins and blood plasma therapies unavoidable.
How the Plasma Therapy Market report helps you? Buy this report to find answers for below questions and how can help you to stay updated • What is the current size of the overall global human plasma therapy market? How much will this market be worth from 2021 to 2031? • How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031? • Who are the leading companies and what are their activities, results, developments and prospects? • What are some of the most prominent human plasma therapy currently in development? • What are the main trends that will affect the world plasma therapy market between 2021 and 2031? • What are the main strengths, weaknesses, opportunities and threats for the market? • What are the social, technological, economic and political influences that will shape that industry over the next ten years? • How will the global plasma therapy market evolve over the forecasted period, 2021 to 2031? • How will the market shares for each checkpoint inhibitor anti-cancer treatment submarket develop from 2021 to 2031? • Which therapies can succeed and what revenues could they generate to 2031? • What will be the main commercial drivers for the market from 2021 to 2031? • How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth? • How will that industry evolve between 2021 and 2031, especially in R&D?
Leading Players Profiled in the Report • Biotest AG • CSL Limited • Grifols International S.A • China Biologic Products Holdings, Inc. • Terumo Corporation • Johnson & Johnson • Zimmer Biomet Holdings, Inc. • Stryker Corporation • Thermogenesis Holdings, Inc., • Nuo Therapeutics, Inc.,
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the precision cancer diagnostic tests Market and leading companies. You will find data, trends and predictions.
Buy our report today Plasma Therapy Market Report 2021-2031: Forecasts by Source (Autologous, Allogenic, Other Sources), by Application (Orthopaedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, Other Applications), by Type (Pure PRP, Leucocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)), by End-user (Hospitals, Clinics & Care Centres, Research Institutes, Other End-user) and Leading National Market Analysis PLUS Analysis of Leading Plasma Therapy Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1 Report Overview 1.1 Why You Should Buy This Report 1.2 How This Report Delivers 1.3 Key Questions Answered by This Analytical Report Include: 1.4 Who is This Report For? 1.5 Methodology 1.1.1 Primary Research 1.1.2 Secondary Research 1.1.3 Data Sources 1.6 Market Evaluation & Forecasting Methodology 1.7 COIVD-19 Impact Recovery Pattern Analysis 1.1.4 V-Shaped Recovery 1.1.5 U-Shaped Recovery 1.1.6 W-Shaped Recovery 1.1.7 L-Shaped Recovery 1.8 Frequently Asked Questions (FAQ) 1.9 Associated Visiongain Reports 1.10 About Visiongain
2 Executive Summary
3 Blood Plasma Products and Technology Overview 3.1 Introduction to Blood Plasma Products 3.2 Components of Blood Plasma 3.3 Functions of Blood Plasma 3.4 Blood Donation 3.5 Collection and Extraction of Blood Plasma 3.6 Fractionation Methods for Extracting Individual Components from Plasma 3.7 Mode of Delivery for Blood Plasma 3.7.1 Infusion Solutions 3.7.2 Gels 3.7.3 Sprays 3.7.4 Biomedical Sealants 3.8 Government Funding of Blood Donation Facilities 3.9 Government Regulations: FDA, International Regulatory Agencies and Medical Associations 3.10 Clinical Guidelines 3.11 Technology Trends
5 Market Drivers, Restraints and Challenges 5.1 Market Dynamics 5.2 Which are the Growth Drivers in the Blood Plasma Market 5.2.1 How Increased Demand for Immunoglobulins in Therapeutic Treatments is Driving the Market? 5.2.2 Is Rising Prevalence of Alpha-1 Antitrypsin Deficiency (AATD) Increasing Demand for Blood Plasma Therapy? 5.2.3 How Increased Geriatric Population Worldwide is Creating Opportunities in the Market? 5.2.4 How Increase in Blood Donations can Help Plasma Therapy Market to Grow? 5.3 Which are the Restraints Factors in the Market? 5.3.1 Increasing Employment of Recombinant Plasma Products in Therapeutic Treatments 5.3.2 Is High Costs Associated with Blood Plasma Therapies Hampering the Growth? 5.3.3 How Stringent Government Regulations and Low Reimbursement Policies are Restraining Market Growth? 5.4 Which are the Opportunities in Global Blood Plasma Market? 5.4.1 Rising Incidence of Haemophilia, Is It Really Driving the Demand? 5.4.2 What are Opportunities in Emerging Nations? 5.5 SWOT Analysis of Blood Plasma Therapy Market 5.5.1 Strengths 5.5.1.1 Ageing Population Driving Need for Plasma Therapies 5.5.1.2 Demand from Emerging Markets Continue 5.5.1.3 Promising R&D Pipeline in the Plasma Therapy Market 5.5.1.4 Increasing awareness of benefits of plasma therapy 5.5.2 Weakness 5.5.2.1 High Costs Associated with Blood Plasma Therapy 5.5.2.2 Barriers to Plasma Therapy Market Entry 5.5.3 Opportunities 5.5.3.1 Constant Improvements in Plasma Technology and Delivery Methods 5.53.2 The Method of Delivery for Plasma Will Be Subject to Innovation Too 5.5.4 Threats 5.5.4.1 Approval Process for New Plasma Therapies Is Overseen by Various Regulatory Bodies 5.5.4.2 Productivity Gap in the Plasma Therapy Market 5.6 Porter’s Five Forces Analysis of Blood Plasma Therapy Market 5.6.1 Bargaining Power of Suppliers 5.6.2 Bargaining Power of Buyers 5.6.3 Threat of New Suppliers 5.6.4 Threat of Substitutes 5.6.5 Competitive Rivalry/Degree of Competition
6 Global Blood Plasma Therapy Market 6.1 Market Value Estimates and Forecast (V, W, U, L Shaped Recovery Analysis) 6.2 Regional Market Value Estimates and Forecast (V, W, U, L Shaped Recovery Analysis) 6.3 Source Market Value Estimates and Forecast (V, W, U, L Shaped Recovery Analysis) 6.3.1 Autologous blood transfusion (ABT) 6.3.2 Allogenic Blood Transfusion (ABT) 6.4 Application Market Value Estimates and Forecast (V, W, U, L Shaped Recovery Analysis) 6.4.1 Orthopaedics 6.4.2 Dermatology 6.4.3 Dental 6.4.4 Cardiac Muscle Injury 6.4.5 Nerve Injury 6.5 Type Market Value Estimates and Forecast (V, W, U, L Shaped Recovery Analysis) 6.5.1 Pure Platelet rich plasma (PRP) 6.5.2 Leucocyte-rich PRP 6.5.3 Pure Platelet-rich Fibrin (PRF) 6.5.4 Leukocyte-rich Fibrin (L-PRF) 6.6 End-User Market Value Estimates and Forecast (V, W, U, L Shaped Recovery Analysis) 6.6.1 Hospitals and Clinics 6.6.2 Research Laboratories 6.6.3 Academic Institutions 6.6.4 Blood Transfusion Centers
7 North America Blood Plasma Therapy Market Analysis 7.1 North America Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 7.2 North America Blood Plasma Therapy Market Size Estimates and Forecast by Country (V, W, U, L Shaped Recovery Analysis) 7.3 In the US Growing Use Of Albumin In Other Therapeutic Areas Driving the Market 7.3.1 US Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 7.4 Canada: Treatment Of Chronic Diseases Driving The Market 7.4.1 Canada Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 7.5 North America Blood Plasma Therapy Market Size Estimates and Forecast by Source (V, W, U, L Shaped Recovery Analysis) 7.6 North America Blood Plasma Therapy Market Size Estimates and Forecast by Application (V, W, U, L Shaped Recovery Analysis) 7.7 North America Blood Plasma Therapy Market Size Estimates and Forecast by Type (V, W, U, L Shaped Recovery Analysis) 7.8 North America Blood Plasma Therapy Market Size Estimates and Forecast by End-User (V, W, U, L Shaped Recovery Analysis)
8 Europe Blood Plasma Therapy Market Analysis 8.1 Europe Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 8.2 Europe Blood Plasma Therapy Market Size Estimates and Forecast by Country (V, W, U, L Shaped Recovery Analysis) 8.3 Russia: Increasing Prevalence Of Life-Threatening Diseases 8.3.1 Russia Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 8.4 Germany: Highest Rates Of Plasma Donations 8.4.1 Germany Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 8.5 UK: Major Disorders Related To Immunodeficiency Is Driving The Market 8.5.1 UK Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 8.6 France is a major contributor to the European blood plasma market 8.6.1 France Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 8.7 Italy Has A Large Market For Blood Plasma Products 8.7.1 Italy Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 8.8 Rest of Europe Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 8.9 Europe Blood Plasma Therapy Market Size Estimates and Forecast by Source (V, W, U, L Shaped Recovery Analysis) 8.10 Europe Blood Plasma Therapy Market Size Estimates and Forecast by Application (V, W, U, L Shaped Recovery Analysis) 8.11 Europe Blood Plasma Therapy Market Size Estimates and Forecast by Type (V, W, U, L Shaped Recovery Analysis) 8.12 Europe Blood Plasma Therapy Market Size Estimates and Forecast by End-User (V, W, U, L Shaped Recovery Analysis)
9 Asia-Pacific Blood Plasma Therapy Market Analysis 9.1 Asia-Pacific Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 9.2 Asia-Pacific Blood Plasma Therapy Market Size Estimates and Forecast by Country (V, W, U, L Shaped Recovery Analysis) 9.3 In Japan Several organizations in Japan ensure the adequacy of blood plasma supplies 9.3.1 Japan Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 9.4 China To Offer Profitable Opportunities In The Years Ahead 9.4.1 China Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 9.5 India Is A Lucrative Blood Plasma Products Market 9.5.1 India Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 9.6 South Korea Is Not Self-Sufficient In Fulfilling Its Demand For Blood Plasma 9.6.1 South Korea Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 9.7 In Australia Increased Demand For Intravenous Immunoglobulins (IVIg) is Driving the Market 9.7.1 Australia Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 9.8 Rest of APAC Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 9.9 Asia-Pacific Blood Plasma Therapy Market Size Estimates and Forecast by Source (V, W, U, L Shaped Recovery Analysis) 9.10 Asia-Pacific Blood Plasma Therapy Market Size Estimates and Forecast by Application (V, W, U, L Shaped Recovery Analysis) 9.11 Asia-Pacific Blood Plasma Therapy Market Size Estimates and Forecast by Type (V, W, U, L Shaped Recovery Analysis) 9.12 Asia-Pacific Blood Plasma Therapy Market Size Estimates and Forecast by End-User (V, W, U, L Shaped Recovery Analysis)
10 LAMEA Blood Plasma Therapy Market Analysis 10.1 LAMEA Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 10.2 LAMEA Blood Plasma Therapy Market Size Estimates and Forecast by Country (V, W, U, L Shaped Recovery Analysis) 10.3 Brazil Has the Potential to Expand in Coming Years 10.3.1 Brazil Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 10.4 Saudi Arabia is Taking the Initiative In The Development Of Healthcare Sectors 10.4.1 Saudi Arabia Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 10.5 In South Africa An Increase In The Consumption Of Blood Products Driving the Market 10.5.1 South Africa Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 10.6 Mexico 10.6.1 Mexico Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 10.7 UAE Provides Essential Novel Blood Plasma Therapies 10.7.1 UAE Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 10.8 Rest of LAMEA Blood Plasma Therapy Market Size Estimates and Forecast by Value (V, W, U, L Shaped Recovery Analysis) 10.9 LAMEA Blood Plasma Therapy Market Size Estimates and Forecast by Source (V, W, U, L Shaped Recovery Analysis) 10.10 LAMEA Blood Plasma Therapy Market Size Estimates and Forecast by Application (V, W, U, L Shaped Recovery Analysis) 10.11 LAMEA Blood Plasma Therapy Market Size Estimates and Forecast by Type (V, W, U, L Shaped Recovery Analysis) 10.12 LAMEA Blood Plasma Therapy Market Size Estimates and Forecast by End-User (V, W, U, L Shaped Recovery Analysis)
11 Top Company Profiles 11.1 Biotest AG Company 11.1.1 Company Information, 2020 11.1.2 Company Overview 11.1.3 Company Financial Profile, 2015-2019 11.1.4 Company Product Offerings 11.1.5 Company Recent Developments, 2020 11.2 CSL Ltd. Company 11.2.1 Company Information 11.2.2 Company Overview 11.2.3 Company Financial Profile 11.2.4 Company Product Offerings 11.2.5 Company Recent Developments 11.3 Grifols International S.A. Company 11.3.1 Company Information 11.3.2 Company Overview 11.3.3 Company Financial Profile 11.3.4 Company Product Offerings 11.3.5 Company Recent Developments 11.4 China Biologic Products Holdings, Inc Company 11.4.1 Company Information 11.4.2 Company Overview 11.4.3 Company Financial Profile 11.4.4 Company Product Offerings 11.4.5 Company Recent Developments 11.5 Terumo Corporation Company 11.5.1 Company Information 11.5.2 Company Overview 11.5.3 Company Financial Profile 11.5.4 Company Product Offerings 11.5.5 Company Recent Developments 11.6 Johnson & Johnson Medical Device Company 11.6.1 Company Information 11.6.2 Company Overview 11.6.3 Company Financial Profile 11.6.4 Company Product Offerings 11.6.5 Company Recent Developments 11.7 Zimmer Biomet Holdings Inc Company 11.7.1 Company Information 11.7.2 Company Overview 11.7.3 Company Financial Profile 11.7.4 Company Product Offerings 11.7.5 Company Recent Developments 11.8 Stryker Corporation Company 11.8.1 Company Information 11.8.2 Company Overview 11.8.3 Company Financial Profile 11.8.4 Company Product Offerings 11.8.5 Company Recent Developments 11.9 Thermogenesis holdings inc. Company 11.9.1 Company Information 11.9.2 Company Overview 11.9.3 Company Financial Profile 11.9.4 Company Product Offerings 11.9.5 Company Recent Developments 11.10 Nuo Therapeutics, Inc Company 11.10.1 Company Information 11.10.2 Company Overview 11.10.3 Company Financial Profile 11.10.4 Company Product Offerings 11.11 Competitive Landscape of Blood Plasma Market 11.11.1 Major Players and Market Shares 11.12 List of Other Companies 11.13 List of Blood Plasma Related Organizations
12 Conclusion & Recommendations 12 12.1 Concluding Remarks 12 12.2 Recommendation for Industry Players
List of Figures Figure 6.1 Global Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) Figure 6.2 Global Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 6.3 Global Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 6.4 Global Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 6.5 Global Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 6.6 Global Plasma Therapy Market by Region Forecast 2021-2031 (US$ million, AGR %) Figure 6.7 Global Plasma Therapy Market by Region Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 6.8 Global Plasma Therapy Market by Region Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 6.9 Global Plasma Therapy Market by Region Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 6.10 Global Plasma Therapy Market by Region Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 6.11 Global Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) Figure 6.12 Global Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 6.13 Global Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 6.14 Global Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 6.15 Global Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 6.16 Global Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) Figure 6.17 Global Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 6.18 Global Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 6.19 Global Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 6.20 Global Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 6.21 Global Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) Figure 6.22 Global Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 6.23 Global Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 6.24 Global Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 6.25 Global Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 6.26 Global Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) Figure 6.27 Global Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 6.28 Global Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 6.29 Global Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 6.30 Global Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 7.1 North America Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) Figure 7.2 North America Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 7.3 North America Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 7.4 North America Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 7.5 North America Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 7.6 North America Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) Figure 7.7 North America Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 7.8 North America Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 7.9 North America Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 7.10 North America Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 7.11 North America Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) Figure 7.12 North America Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 7.13 North America Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 7.14 North America Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 7.15 North America Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 7.16 North America Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) Figure 7.17 North America Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 7.18 North America Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 7.19 North America Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 7.20 North America Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 7.21 North America Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) Figure 7.22 North America Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 7.23 North America Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 7.24 North America Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 7.25 North America Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 7.26 North America Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) Figure 7.27 North America Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 7.28 North America Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 7.29 North America Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 7.30 North America Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 8.1 Europe Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) Figure 8.2 Europe Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 8.3 Europe Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 8.4 Europe Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 8.5 Europe Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 8.6 Europe Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) Figure 8.7 Europe Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 8.8 Europe Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 8.9 Europe Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 8.10 Europe Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 8.11 Europe Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) Figure 8.12 Europe Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 8.13 Europe Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 8.14 Europe Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 8.15 Europe Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 8.16 Europe Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) Figure 8.17 Europe Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 8.18 Europe Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 8.19 Europe Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 8.20 Europe Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 8.21 Europe Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) Figure 8.22 Europe Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 8.23 Europe Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 8.24 Europe Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 8.25 Europe Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 8.26 Europe Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) Figure 8.27 Europe Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 8.28 Europe Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 8.29 Europe Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 8.30 Europe Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 9.1 Asia-Pacific Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) Figure 9.2 Asia-Pacific Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 9.3 Asia-Pacific Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 9.4 Asia-Pacific Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 9.5 Asia-Pacific Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 9.6 Asia-Pacific Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) Figure 9.7 Asia-Pacific Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 9.8 Asia-Pacific Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 9.9 Asia-Pacific Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 9.10 Asia-Pacific Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 9.11 Asia-Pacific Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) Figure 9.12 Asia-Pacific Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 9.13 Asia-Pacific Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 9.14 Asia-Pacific Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 9.15 Asia-Pacific Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 9.16 Asia-Pacific Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) Figure 9.17 Asia-Pacific Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 9.18 Asia-Pacific Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 9.19 Asia-Pacific Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 9.20 Asia-Pacific Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 9.21 Asia-Pacific Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) Figure 9.22 Asia-Pacific Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 9.23 Asia-Pacific Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 9.24 Asia-Pacific Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 9.25 Asia-Pacific Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 9.26 Asia-Pacific Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) Figure 9.27 Asia-Pacific Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 9.28 Asia-Pacific Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 9.29 Asia-Pacific Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 9.30 Asia-Pacific Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 10.1 LAMEA Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) Figure 10.2 LAMEA Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 10.3 LAMEA Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 10.4 LAMEA Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 10.5 LAMEA Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 10.6 LAMEA Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) Figure 10.7 LAMEA Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 10.8 LAMEA Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 10.9 LAMEA Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 10.10 LAMEA Plasma Therapy Market by Country Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 10.11 LAMEA Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) Figure 10.12 LAMEA Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 10.13 LAMEA Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 10.14 LAMEA Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 10.15 LAMEA Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 10.16 LAMEA Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) Figure 10.17 LAMEA Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 10.18 LAMEA Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 10.19 LAMEA Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 10.20 LAMEA Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 10.21 LAMEA Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) Figure 10.22 LAMEA Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 10.23 LAMEA Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 10.24 LAMEA Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 10.25 LAMEA Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 10.26 LAMEA Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) Figure 10.27 LAMEA Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (V-Shaped Recovery) Figure 10.28 LAMEA Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (W-Shaped Recovery) Figure 10.29 LAMEA Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (U-Shaped Recovery) Figure 10.30 LAMEA Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %) (L-Shaped Recovery) Figure 11.1 Biotest AG Company: Company Revenue 2015-2019 (US$Mn, AGR %) Figure 11.2 Biotest AG Company: Company Operating Income 2015-2019 (US$Mn) Figure 11.3 Biotest AG. Company: Company EBITDA 2015-2019 (US$Mn) Figure 11.4 Biotest AG. Company: Company Net Income/Loss 2015-2019 (US$Mn) Figure 11.5 CSL Ltd Company: Company Revenue 2015-2019 (US$Mn, AGR %) Figure 11.6 CSL Ltd Company: Company Operating Income 2015-2019 (US$Mn) Figure 11.7 CSL Ltd. Company: Company EBITDA 2015-2019 (US$Mn) Figure 11.8 CSL Ltd. Company: Company Net Income/Loss 2015-2019 (US$Mn) Figure 11.9 Grifols S.A Company: Company Revenue 2015-2019 (US$Mn, AGR %) Figure 11.10 Grifols S.A Company: Company Operating Income 2015-2019 (US$Mn) Figure 11.11 Grifols S.A. Company: Company EBITDA 2015-2019 (US$Mn) Figure 11.12 Grifols S.A. Company: Company Net Income/Loss 2015-2019 (US$Mn) Figure 11.13 China Biologic Products Company: Company Revenue 2015-2019 (US$Mn, AGR %) Figure 11.14 China Biologic Products Company: Company Operating Income 2015-2019 (US$Mn) Figure 11.15 China Biologic Products. Company: Company EBITDA 2015-2019 (US$Mn) Figure 11.16 China Biologic Products. Company: Company Net Income/Loss 2015-2019 (US$Mn) Figure 11.17 Terumo Corporation Company: Company Revenue 2015-2019 (US$Mn, AGR %) Figure 11.18 Terumo Corporation Company: Company Operating Income 2015-2019 (US$Mn) Figure 11.19 Terumo Corporation. Company: Company EBITDA 2015-2019 (US$Mn) Figure 11.20 Terumo Corporation. Company: Company Net Income/Loss 2015-2019 (US$Mn) Figure 11.21 J&J Company: Company Revenue 2015-2019 (US$Mn, AGR %) Figure 11.22 J&J Company: Company Operating Income 2015-2019 (US$Mn) Figure 11.23 J&J. Company: Company EBITDA 2015-2019 (US$Mn) Figure 11.24 J&J. Company: Company Net Income/Loss 2015-2019 (US$Mn) Figure 11.25 Zimmer Biomet Holdings Company: Company Revenue 2015-2019 (US$Mn, AGR %) Figure 11.26 Zimmer Biomet Holdings Company: Company Operating Income 2015-2019 (US$Mn) Figure 11.27 Zimmer Biomet Holdings. Company: Company EBITDA 2015-2019 (US$Mn) Figure 11.28 Zimmer Biomet Holdings. Company: Company Net Income/Loss 2015-2019 (US$Mn) Figure 11.29 Stryker Corporation Company: Company Revenue 2015-2019 (US$Mn, AGR %) Figure 11.30 Stryker Corporation Company: Company Operating Income 2015-2019 (US$Mn) Figure 11.31 Stryker Corporation. Company: Company EBITDA 2015-2019 (US$Mn) Figure 11.32 Stryker Corporation. Company: Company Net Income/Loss 2015-2019 (US$Mn) Figure 11.33 Thermogenesis Holdings: Company Revenue 2015-2019 (US$Mn, AGR %) Figure 11.34 Thermogenesis Holdings: Company Operating Income 2015-2019 (US$Mn) Figure 11.35 Thermogenesis Holdings: Company EBITDA 2015-2019 (US$Mn) Figure 11.36 Thermogenesis Holdings: Company Net Income/Loss 2015-2019 (US$Mn) Figure 11.37 Nuo Therapeutics Company: Company Revenue 2015-2019 (US$Mn, AGR %) Figure 11.38 Nuo Therapeutics Company: Company Operating Income 2015-2019 (US$Mn) Figure 11.39 Nuo Therapeutics. Company: Company EBITDA 2015-2019 (US$Mn) Figure 11.40 Nuo Therapeutics. Company: Company Net Income/Loss 2015-2019 (US$Mn)
List of Tables Table 2.1 Global Plasma Therapy Market Summary Table Table 3.1 Blood Plasma Components Table 3.2 Percentage of Major Proteins Present in Different Fractions After Cohn’s Fractionation Method Table 3.3 Key Trends in the Global Blood Plasma Market Table 4.1 China Biologic Product: Company Product Pipeline Table 4.2 1. Grifols International S.A.: Company Product Pipeline Table 4.3 Biotest Inc: Company Product Pipeline Table 4.4 CSL Ltd: Company Product Pipeline Table 6.1 Porter’s Five Forces Analysis: Global Plasma Therapy Market Table 6.1 Global Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 6.2 Global Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 6.3 Global Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 6.4 Global Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 6.5 Global Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 6.6 Global Plasma Therapy Market by Region Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 6.7 Global Plasma Therapy Market by Region Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 6.8 Global Plasma Therapy Market by Region Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 6.9 Global Plasma Therapy Market by Region Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 6.10 Global Plasma Therapy Market by Region Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 6.11 Global Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 6.12 Global Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 6.13 Global Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 6.14 Global Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 6.15 Global Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 6.16 Global Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 6.17 Global Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 6.18 Global Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 6.19 Global Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 6.20 Global Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 6.21 Global Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 6.22 Global Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 6.23 Global Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 6.24 Global Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 6.25 Global Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 6.26 Global Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 6.27 Global Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 6.28 Global Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 6.29 Global Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 6.30 Global Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 7.1 North America Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 7.2 North America Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 7.3 North America Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 7.4 North America Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 7.5 North America Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 7.6 US Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 7.7 US Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 7.8 US Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 7.9 US Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 7.10 US Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 7.11 Canada Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 7.12 Canada Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 7.13 Canada Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 7.14 Canada Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 7.15 Canada Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 7.16 North America Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 7.17 North America Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 7.18 North America Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 7.19 North America Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 7.20 North America Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 7.21 North America Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 7.22 North America Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 7.23 North America Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 7.24 North America Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 7.25 North America Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 7.26 North America Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 7.27 North America Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 7.28 North America Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 7.29 North America Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 7.30 North America Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 7.31 North America Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 7.32 North America Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 7.33 North America Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 7.34 North America Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 7.35 North America Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 8.1 Europe Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 8.2 Europe Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 8.3 Europe Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 8.4 Europe Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 8.5 Europe Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 8.6 Russia Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 8.7 Russia Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 8.8 Russia Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 8.9 Russia Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 8.10 Russia Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 8.11 Germany Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 8.12 Germany Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 8.13 Germany Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 8.14 Germany Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 8.15 Germany Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 8.16 UK Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 8.17 UK Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 8.18 UK Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 8.19 UK Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 8.20 UK Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 8.21 France Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 8.22 France Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 8.23 France Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 8.24 France Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 8.25 France Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 8.26 Italy Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 8.27 Italy Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 8.28 Italy Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 8.29 Italy Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 8.30 Italy Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 8.31 Rest of Europe Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 8.32 Rest of Europe Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 8.33 Rest of Europe Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 8.34 Rest of Europe Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 8.35 Rest of Europe Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 8.36 Europe Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 8.37 Europe Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 8.38 Europe Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 8.39 Europe Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 8.40 Europe Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 8.41 Europe Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 8.42 Europe Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 8.43 Europe Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 8.44 Europe Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 8.45 Europe Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 8.46 Europe Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 8.47 Europe Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 8.48 Europe Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 8.49 Europe Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 8.50 Europe Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 8.51 Europe Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 8.52 Europe Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 8.53 Europe Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 8.54 Europe Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 8.55 Europe Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 9.1 Asia-Pacific Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 9.2 Asia-Pacific Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 9.3 Asia-Pacific Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 9.4 Asia-Pacific Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 9.5 Asia-Pacific Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 9.6 Japan Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 9.7 Japan Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 9.8 Japan Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 9.9 Japan Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 9.10 Japan Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 9.11 China Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 9.12 China Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 9.13 China Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 9.14 China Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 9.15 China Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 9.16 India Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 9.17 India Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 9.18 India Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 9.19 India Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 9.20 India Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 9.21 South Korea Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 9.22 South Korea Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 9.23 South Korea Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 9.24 South Korea Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 9.25 South Korea Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 9.26 Australia Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 9.27 Australia Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 9.28 Australia Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 9.29 Australia Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 9.30 Australia Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 9.31 Rest of Asia-Pacific Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 9.32 Rest of Asia-Pacific Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 9.33 Rest of Asia-Pacific Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 9.34 Rest of Asia-Pacific Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 9.35 Rest of Asia-Pacific Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 9.36 Asia-Pacific Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 9.37 Asia-Pacific Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 9.38 Asia-Pacific Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 9.39 Asia-Pacific Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 9.40 Asia-Pacific Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 9.41 Asia-Pacific Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 9.42 Asia-Pacific Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 9.43 Asia-Pacific Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 9.44 Asia-Pacific Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 9.45 Asia-Pacific Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 9.46 Asia-Pacific Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 9.47 Asia-Pacific Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 9.48 Asia-Pacific Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 9.49 Asia-Pacific Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 9.50 Asia-Pacific Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 9.51 Asia-Pacific Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 9.52 Asia-Pacific Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 9.53 Asia-Pacific Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 9.54 Asia-Pacific Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 9.55 Asia-Pacific Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 10.1 LAMEA Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 10.2 LAMEA Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 10.3 LAMEA Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 10.4 LAMEA Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 10.5 LAMEA Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 10.6 Brazil Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 10.7 Brazil Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 10.8 Brazil Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 10.9 Brazil Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 10.10 Brazil Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 10.11 Saudi Arabia Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 10.12 Saudi Arabia Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 10.13 Saudi Arabia Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 10.14 Saudi Arabia Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 10.15 Saudi Arabia Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 10.16 South Africa Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 10.17 South Africa Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 10.18 South Africa Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 10.19 South Africa Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 10.20 South Africa Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 10.21 Mexico Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 10.22 Mexico Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 10.23 Mexico Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 10.24 Mexico Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 10.25 Mexico Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 10.26 UAE Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 10.27 UAE Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 10.28 UAE Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 10.29 UAE Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 10.30 UAE Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 10.31 Rest of LAMEA Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 10.32 Rest of LAMEA Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 10.33 Rest of LAMEA Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 10.34 Rest of LAMEA Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 10.35 Rest of LAMEA Plasma Therapy Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 10.36 LAMEA Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 10.37 LAMEA Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 10.38 LAMEA Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 10.39 LAMEA Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 10.40 LAMEA Plasma Therapy Market by Source Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 10.41 LAMEA Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 10.42 LAMEA Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 10.43 LAMEA Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 10.44 LAMEA Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 10.45 LAMEA Plasma Therapy Market by Application Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 10.46 LAMEA Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 10.47 LAMEA Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 10.48 LAMEA Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 10.49 LAMEA Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 10.50 LAMEA Plasma Therapy Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 10.51 LAMEA Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) Table 10.52 LAMEA Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped Recovery) Table 10.53 LAMEA Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped Recovery) Table 10.54 LAMEA Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped Recovery) Table 10.55 LAMEA Plasma Therapy Market by End-User Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped Recovery) Table 11.1 Biotest AG: Company Information Table 11.2 Biotest AG Company: Company Revenue 2015-2019 (US$Mn, AGR %) Table 11.3 Biotest AG: Company Product and Service Offerings Table 11.4 Biotest AG: Company Recent Developments till Sept,2020 Table 11.5 CSL Ltd: Company Information Table 11.6 CSL Ltd Company: Company Revenue 2015-2019 (US$Mn, AGR %) Table 11.7 CSL Ltd: Company Product and Service Offerings Table 11.8 CSL Ltd: Company Recent Developments till Sept,2020 Table 11.9 Grifols International S.A: Company Information Table 11.10 Grifols S.A Company: Company Revenue 2015-2019 (US$Mn, AGR %) Table 11.11 Grifols S.A: Company Product and Service Offerings Table 11.12 Grifols S.A: Company Recent Developments till Sept,2020 Table 11.13 China Biologic Products: Company Information Table 11.14 China Biologic Products Company: Company Revenue 2015-2019 (US$Mn, AGR %) Table 11.15 China Biologic Products: Company Product and Service Offerings Table 11.16 China Biologic Products: Company Recent Developments till Sept,2020 Table 11.17 Terumo Corporation: Company Information Table 11.18 Terumo Corporation Company: Company Revenue 2015-2019 (US$Mn, AGR %) Table 11.19 Terumo Corporation: Company Product and Service Offerings Table 11.20 Terumo Corporation: Company Recent Developments till Sept,2020 Table 11.21 J&J: Company Information Table 11.22 J&J Company: Company Revenue 2015-2019 (US$Mn, AGR %) Table 11.23 J&J: Company Product and Service Offerings Table 11.24 J&J: Company Recent Developments till Sept,2020 Table 11.25 Zimmer Biomet Holdings Inc: Company Information Table 11.26 Zimmer Biomet Holdings Company: Company Revenue 2015-2019 (US$Mn, AGR %) Table 11.27 Zimmer Biomet Holdings: Company Product and Service Offerings Table 11.28 Zimmer Biomet Holdings: Company Recent Developments till Sept,2020 Table 11.29 Stryker Corporation: Company Information Table 11.30 Stryker Corporation Company: Company Revenue 2015-2019 (US$Mn, AGR %) Table 11.31 Stryker Corporation: Company Product and Service Offerings Table 11.32 Stryker Corporation: Company Recent Developments till Sept,2020 Table 11.33 Thermogenesis Holdings: Company Information Table 11.34 Thermogenesis Holdings: Company Revenue 2015-2019 (US$Mn, AGR %) Table 11.35 Thermogenesis Holdings: Company Product and Service Offerings Table 11.36 Thermogenesis Holdings: Company Recent Developments till Sept,2020 Table 11.37 Nuo Therapeutics: Company Information Table 11.38 Nuo Therapeutics Company: Company Revenue 2015-2019 (US$Mn, AGR %) Table 11.39 Nuo Therapeutics: Company Product and Service Offerings
List of Companies Profiled Biotest AG China Biologic Products Holdings, Inc. CSL Limited Grifols International S.A Johnson & Johnson Nuo Therapeutics, Inc., Stryker Corporation Terumo Corporation Thermogenesis Holdings, Inc., Zimmer Biomet Holdings, Inc.
List of Other Companies AABB Alexion Pharmaceuticals America’s Blood Centers American Red Cross Asahi Kasei Pharma America Australian Red Cross Baxalta BAXALTA Gmbh Bayer Biomarin Pharmaceutical Bioverativ Therapeutics Bluebird Bio Canadian Plasma Resources Csl Behring Erytech Pharma Ethicon Fresenius Kabi Genentech Gigagen Global Blood Therapeutics Grifols Immucor GTI Diagnostics IPFA Japan Blood Products Org Jeffrey Modell Foundation Km Biologics NIHON PHARMA Novo Nordisk PFIZER Ppta Prometic Life Sciences Prometic Plasma Resources Roche Sanofi Spark Therapeutics Swedish Orphan Biovitrum Takeda VERSITI
List of Organizations Mentioned in the Report Belgium Red Cross Central Fractionation Facility Canadian Blood Agency Canadian Blood Services (CBS) Center for Biologics Evaluation and Research (CBER) Chemo-Sero Therapeutic Research Institute (Kaketsuken) Food and Drug Administration (FDA) Japan Blood Products Organization Japanese Red Cross Society (JRCS) National Bioproducts Institute National Blood Service (NBS) National Genetics Institute National Health Service (NHS) New Zealand Blood Service Sanquin Blood Supply Foundation Southern Blood Services The Plasma Protein Therapeutics Association (PPTA) University of Massachusetts Medical School World Health Organizations (WHO)
Download sample pages
Complete the form below to download your free sample pages for Plasma Therapy Market Report 2021-2031
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033
The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.
The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.
The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.
Visiongain Publishes Regenerative Medicine Market Report 2023-2033
The global Regenerative Medicine market was valued at US$ 50.37 billion in 2022 and is projected to grow at a CAGR of 18.40% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
